Zobrazeno 1 - 10
of 251
pro vyhledávání: '"F, Crokaert"'
Publikováno v:
Clinical Drug Investigation. 16:161-166
Objectives: The pharmacokinetics of azithromycin were evaluated in 12 healthy volunteers. Methods: This was an open study in 12 healthy male subjects. Participants received a single dose of 2 x 250mg azithromycin (two azithromycin capsules) administe
Autor:
I Langenaeken, Thierry Calandra, M. P. Glauser, A Padmos, Marianne Paesmans, A Del Favero, Stephen H. Zinner, F Crokaert, R. De Bock, Jean Klastersky, W V Kern, H Gaya, C Viscoli, G Bucaneve, A Micozzi, A. Cometta
Publikováno v:
Europe PubMed Central
Combinations of beta-lactams plus aminoglycosides have been standard therapy for suspected infections in granulocytopenic cancer patients, especially those with profound long-lasting granulocytopenia. With the advent of new broad-spectrum bactericida
Autor:
D. Fiere, John H. Rex, Thomas F. Patterson, O. Lortholary, Thomas J. Walsh, J. E. Edwards, B.E. de Pauw, David W. Denning, Sibel Ascioglu, Palak Shah, Jacques F. Meis, F. Crokaert, D. Selleslag, J.P. Donnelly, J. Bille, J. Ritter, John E. Bennett, Johan Maertens, Z. Erjavec, David A. Stevens
Publikováno v:
Ascioglu, S, Rex, J H, De Pauw, B, Bennett, J E, Bille, J, Crokaert, F, Denning, D W, Donnelly, J P, Edwards, J E, Erjavec, Z, Fiere, D, Lortholary, O, Maertens, J, Meis, J F, Patterson, T F, Ritter, J, Selleslag, D, Shah, P M, Stevens, D A & Walsh, T J 2002, ' Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants : An international consensus ', Clinical Infectious Diseases, vol. 34, no. 1, pp. 7-14 . https://doi.org/10.1086/323335
Clinical Infectious Diseases, 34, 1, pp. 7-14
Clinical Infectious Diseases, 34, 7-14
Clinical Infectious Diseases, 34, 1, pp. 7-14
Clinical Infectious Diseases, 34, 7-14
Item does not contain fulltext During the past several decades, there has been a steady increase in the frequency of opportunistic invasive fungal infections (IFIs) in immunocompromised patients. However, there is substantial controversy concerning o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6709c911000a01079d5a44e4e720a18f
https://doi.org/10.1086/323335
https://doi.org/10.1086/323335
Autor:
M, Viot, M P, Blanc-Vincent, J, Béal, P, Biron, P, Boutard, V B, Malgrange, F, Crokaert, M C, Escande, C, Fuhrmann, T, Lesimple, J, Pény, B, Pottecher, J, Raveneau, J M, Senet, A, Thyss
Publikováno v:
Presse medicale (Paris, France : 1983). 29(29)
The main risk factors of infectious complications in cancer patients result from immune deficiency more or less related to cancer. Prognosis is related to the type and grade of the underlying disease. Prospective studies should be conducted to update
Autor:
V, Bussy Malgrange, M P, Blanc-Vincent, M C, Escande, C, Fuhrmann, J, Béal, F, Boineau, P, Biron, F, Crokaert, T, Lesimple, B, Pottecher, J, Raveneau, J M, Senet, M, Viot
Publikováno v:
Presse medicale (Paris, France : 1983). 29(27)
Excepting emergency and aplasia: two to three blood samples should be draw for culture an hour apart within a 24 period (standard). For emergency or aplasia: two to three blood samples should be drawn for culture before initiating early antibiotic th
Autor:
B, Pottecher, R, Herbrecht, M P, Blanc-Vincent, V, Bussy Malgrange, M C, Escande, C, Fuhrmann, F, Crokaert, G, Gory-Delabaere, J M, Senet, T, Lesimple, J, Raveneau, J, Béal, P, Biron, M, Viot
Publikováno v:
Bulletin du cancer. 87(7-8)
The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of the French Cancer Centres (FNCLCC), the 20 French Cancer Centres and specialists from French Public Universities, General Hospit
Autor:
P, Biron, C, Fuhrmann, M C, Escande, M P, Blanc-Vincent, F, Crokaert, J, Béal, V, Bussy, T, Lesimple, B, Pottecher, J, Raveneau, J M, Senet, M, Viot
Publikováno v:
Bulletin du cancer. 85(8)
The "Standards, Options and Recommendations" (SOR), initiated in 1993, is a collaborative project between the Federation of the French Cancer Centres (FNCLCC), the 20 French Cancer Centres and specialists from French Public Universities, General Hosp
Publikováno v:
Chemotherapy. 38(1)
A new method of data presentation that takes into account the relationship between growth and killing rate was used to evaluate the comparative in vitro bactericidal activity of cefpodoxime, cefuroxime, cefixime and an amoxicillin/clavulanic acid com
Publikováno v:
Chemotherapy. 37(1)
Phase contrast microscopy, killing curves and turbidimetric growth curves were used in a comparative study of the antibacterial effects of imipenem and meropenem on Haemophilus influenzae. The minimal inhibitory concentrations (MICs) and their ranges
Publikováno v:
Chemotherapy. 36(3)
Tazobactam, a non-amino penicillanic acid sulfone, is a new beta-lactamase inhibitor and acts synergistically with piperacillin against clinical isolates of beta-lactamase-producing Bacteroides fragilis. The effectiveness of this inhibitor has been d